Insider trades

Yvonne Greenstreet, CEO of Alnylam Pharmaceuticals ALNY, has filed 0 purchases and 149 sales on the open market. Over the past 12 months that comes to a net sale of $24.5M. The latest trade was on 03/04.

Yvonne Greenstreet

CEO
First filing
23/03/01
Trades
205 trades
Buys / sales
0 / 149
12-month net buying
−$24.5M
Last trade
03/04

Trading activity

Transactions

Trade type
ALNY
Open-market sale03/0403/062,933 sh8 trades$323.08avg.$947,580.95−3.0%
ALNY
Open-market sale03/0203/046,799 sh10 trades$327.65avg.$2,227,698.49−6.4%
Open-market sale02/1302/176,958 sh$310.08$2,157,536.64−7.5%
ALNY
Open-market sale01/1201/149,577 sh21 trades$362.86avg.$3,475,156.51−10.9%
ALNY
Open-market sale10b5-1 plan25/11/12–25/11/1325/11/1425,650 sh20 trades$452.75avg.$11,613,003.42−28.2%
ALNY
Open-market sale25/10/0225/10/038,924 sh12 trades$452.05avg.$4,034,084.66−12.0%
ALNY
Open-market sale25/08/1825/08/196,979 sh8 trades$453.27avg.$3,163,345.74−11.0%
ALNY
Open-market sale10b5-1 plan25/05/30–25/06/0225/06/0350,937 sh3 trades$305.00avg.$15,535,784−51.0%
ALNY
Open-market sale25/03/0325/03/053,877 sh7 trades$243.79avg.$945,164.88−3.8%
ALNY
Open-market sale25/02/2825/03/032,900 sh8 trades$241.69avg.$700,893.68−3.3%
ALNY
Open-market sale25/02/1425/02/181,213 sh12 trades$255.17avg.$309,526.58−1.5%
ALNY
Open-market sale24/11/2624/11/275,219 sh5 trades$250.98avg.$1,309,852.75−6.2%
Open-market sale10b5-1 plan24/08/2024/08/2215,000 sh$280.00$4,200,000−17.0%
Open-market sale10b5-1 plan24/08/0124/08/0215,148 sh$270.00$4,089,960−17.1%
Open-market sale10b5-1 plan24/07/1124/07/127,093 sh$261.00$1,851,273−8.8%
ALNY
Open-market sale24/06/2524/06/268,301 sh12 trades$230.99avg.$1,917,475.08−9.3%
ALNY
Open-market sale24/02/2824/02/292,932 sh5 trades$155.31avg.$455,357.07−5.7%
ALNY
Open-market sale24/02/1624/02/207,030 sh3 trades$148.06avg.$1,040,884.56−13.5%
ALNY
Open-market sale23/08/0423/08/074,057 sh6 trades$185.85avg.$753,986.38−10.3%
ALNY
Open-market sale23/04/2723/04/287,615 sh5 trades$194.59avg.$1,481,811.47−20.1%